(Q36068142)

12 August 2017

Serum visfatin levels, adiposity and glucose metabolism in obese adolescents (English)

1 reference

12 August 2017

0 references

1 reference

Derya Taşkesen

1

1 reference

PMCID

3386777

12 August 2017

Birgül Kirel

series ordinal

2

1 reference

PMCID

3386777

12 August 2017

Tercan Us

series ordinal

3

1 reference

12 August 2017

1 June 2012

1 reference

Journal of clinical research in pediatric endocrinology

12 August 2017

1 reference

12 August 2017

4

1 reference

12 August 2017

2

1 reference

12 August 2017

76-81

1 reference

Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

An evaluation of visfatin levels in obese subjects.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Plasma visfatin concentrations in subjects with type 1 diabetes mellitus.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Plasma visfatin concentrations in childhood obesity: relationships with insulin resistance and anthropometric indices

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Intensive glycemic control lowers plasma visfatin levels in patients with type 2 diabetes

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

The visfatin gene is associated with glucose and lipid metabolism in a Chinese population.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

The release of the adipocytokine visfatin is regulated by glucose and insulin.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Visfatin is an adipokine, but it is not regulated by thiazolidinediones

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3386777

Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis

23 September 2018

1 reference

12 December 2020

The relationship between visfatin and HOMA-IR in hypertensive patients, and the effect of antihypertensive drugs on visfatin and HOMA-IR in hypertensive patients with insulin resistance

1 reference

12 December 2020

Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Body mass index references for Turkish children

1 reference

12 December 2020

Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans

1 reference

12 December 2020

Serum visfatin increases with progressive beta-cell deterioration

1 reference

12 December 2020

The adipokine visfatin is markedly elevated in obese children

1 reference

12 December 2020

The metabolic syndrome in children and adolescents

1 reference

12 December 2020

Serum concentration of visfatin in obese women

1 reference

12 December 2020

Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children

1 reference

12 December 2020

Identifiers

DOI

10.4274/JCRPE.547

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

PMCID

3386777